Brief-Illness Perception Questionnaire (Brief-IPQ) Used in Patients With Chronic Non-malignant Pain

Sponsor
Zealand University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05535335
Collaborator
(none)
364
1
21.9
16.6

Study Details

Study Description

Brief Summary

The investigators wish to investigate if there are any difference in the BIPQ score in persons with chronic low back pain from admission to the Pain Centre at Zealand University Hospital Koege (ZUH), and when discharged.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Chronic pain conditions are frequent in the danish population. More than 1.2 million Danes over the age of 16 are living with chronic pain. Chronic pain affects the health-related quality of life and functioning and is associated with reduced work ability, lost earnings and disability. At the Interdisciplinary Pain Center Zealand University Hospital Koege, Denmark, patients with chronic pain are received and treated based on the Bio-Psycho-Social Pain Model. The treatment of patients with complex chronic non-malignant pain can be complicated by psychological and / or social factors. The need for a screening of psychological factors in connection with the examination and planning of the pain management in the Interdisciplinary Pain Center is obvious as the patient's perception of illness and expectation of treatment have been shown to play a role in the treatment response. The Brief Illness Perception Questionnaire (Brief-IPQ) provides a quick assessment of the patient's disease perception and expectation of treatment and has proved useful in clinical practice. In this study, a Danish version of Brief-IPQ is used, which initially was taken from https://www.uib.no. Items as stated in research by L. van Oort et al (2011) have been adapted to the Danish version. A copy of the latest version can be obtained from Interdisciplinary Pain Center Zealand University Hospital Koege, Denmark.

    The study:
    Participants:

    Patients with chronic low back pain admitted to the Pain Centre after June 2021 at ZUHK.

    • Persons ≥18 years

    • Persons who suffers from chronic back pain and are admitted to the Pain Centre at Zealand University Hospital in Køge, Denmark

    • Persons who have completed the BIPQ both at first and at last visit in the Pain Centre

    Numbers 100 patients with both pre and post admission IBPQ score

    Timeframe The data will be analyzed when there is a full dataset on 100 patients admitted from June 2020

    Location of the study The Pain Centre at Zealand University Hospital, Koege

    The patients will answer the questionnaire including the following data online before visiting the pain Centre and after treatment. Thereby the investigators can estimate the result of treatment compared to the BIPQ score before entry to treatment statistically. and thereby generate estimates concerning the success of pain treatment measured by BIPQ.

    • The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item questionnaire, to assess the confidence people with ongoing pain have in performing activities while in pain.

    • Pain during movement is measured by the Numeric Rating Scale (NRS) from 0 to 10

    • For measuring the patients fear of movement related pain (fear avoidance) the 17 items questionnaire Tampa Scale of Kinesiophobia (TSK) will be used.

    0= No pain at all and 10= worse imaginable pain

    • Pain catastrophizing is measured by the Pain Catastrophizing Scale (PCS) and includes the following items rumination ("I can't stop thinking about how much it hurts"), magnification ("I worry that something serious may happen"), and helplessness ("There is nothing I can do to reduce the intensity of the pain"). The PCS total score is computed by summing responses to all 13 items. PCS total scores range from 0 - 52.

    • Placebo measured with BIPQ. The BIPQ investigates the following; cognitive meaning (consequences, time perspective, personally control, treatment control and identity), emotional meaning (concerns, emotions), understanding of the condition and finally the patient´s own evaluation of the three most important reasons for the condition 8.

    A decrease in BIPQ score will be defined as the mean +/- 1SD as cut-off.

    All data will be derived from the PainData database. An examination is made of whether the patient meets the inclusion or exclusion criteria

    • Data will be stored in an Excel file and the statistical analyses will performed using SPSS

    Ethical aspects:

    All information will be treated confidentially and all data will be anonymized by a secretary. The Investigator will keep an identification list of all patients who have been included. This list will include the patient's full name and CPR number. Collected data will be recorded in a Case Report Form. The results will be stored and analyzed using a computer and the anonymity of the patients will be preserved and local data law will be observed. Data will be stored in accordance with existing regulations. Data is stored in anonymized form and correlation and regression analysis will be performed after 6 months. The study is conducted in accordance with applicable clinical trial rules. Investigators are responsible for the handling and archiving of data in accordance with applicable rules in addition to the Act on the Processing of Personal Data and the Health Act. Data belong to the investigators. The project has been reported to the local ethic committee.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    364 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Brief-Illness Perception Questionnaire (Brief-IPQ) Used as Prediction of Outcome in Patients With Chronic Non-malignant Pain After Treatment in a Multidisciplinary Pain Clinic
    Actual Study Start Date :
    Jun 6, 2020
    Actual Primary Completion Date :
    Apr 3, 2022
    Actual Study Completion Date :
    Apr 3, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Differences in illness perception [Change in Illness peception score Measured at admission and at discharge between the 12-6-2020 - 03-04-2022]

      Change in Brief Illness perception will be measured by using the Brief Illness perception questionnaire. The IPQ-B consists of nine items rated on a scale from 0 (minimum) to 10 (maximum). Illness perception Scores 0-24, low scores, 24-56 moderate, 56- 80 high scores.

    Other Outcome Measures

    1. Differences in Fear Avoidance [Change in Fear avoidance will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022]

      Change in Fear avoidance will be measured by using the 17 items Tampa Scale of Kinesiophobia, Scores range from 17 to 68. Low scores indicate no kinesiophobia and high scores extreme fear of pain with movement. Cut off score = 37.

    2. Differences in Quality of life [Change in Quality of life will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022]

      Change in Quality of life will be measured by using the PROMIS-10 questionnaire.Using T-scores, median = 50, higher scores over 50 indicates wellbeeing.

    3. Differences in Pain Self efficacy [Change in Pain Selv Efficacy will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022]

      Change in Pain Self efficacy will be measured by using the 2 items fra 10 item questionnaire: PSEQ. PSEQ 1 and PSEQ 2. numbers are calculated by summing the numbers. Median = 3, Scores higher than 3 means high confidence, lower than 3 means low confidence.

    4. Differences in Pain Catastrophizing [Change in Pain Catastrophizing will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022]

      Change in Pain Catastrophizing will be measured by using the 13 items Pain Catastrophizing Scale. PCS range from 0 to 52. Subclinical = 0 to 29; Mild = 30 to 39; Moderate = 40 to 49; Severe = 50 to 59; Extreme = 60 to 100.

    5. Differences in Numeric rating scale [Change in Pain intensity during movement measured at admission and at discharge between the 12-6-2020 - 03-04-2022]

      Change in Pain intensity during movement measured from 0-10, where 10 is the worst pain

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients admitted to the multidisciplinary pain clinic at Zealand University Hospital with low back pain

    • Understand Danish spoken and written

    Exclusion Criteria:
    • Patients with insufficient cognitive abilities

    • Patients who decline to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zealand University Hospital Køge Zealand Denmark 4600

    Sponsors and Collaborators

    • Zealand University Hospital

    Investigators

    • Study Director: Anja Geisler, phd., Koge Universitets Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zealand University Hospital
    ClinicalTrials.gov Identifier:
    NCT05535335
    Other Study ID Numbers:
    • REG-1303-2022
    First Posted:
    Sep 10, 2022
    Last Update Posted:
    Sep 10, 2022
    Last Verified:
    Mar 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Zealand University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 10, 2022